Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study. Fifty meta-iodobenzylguanidine (MIBG) scintiscans were performed in three groups of medullary thyroid cancer (MTC) patients. Group 1 (n = 11) included treated patients with normal calcitonin levels Group 2 (n = 24) included patients with elevated calcitonin levels due to sporadic and isolated MTC